Clip
How Immunotherapy and AI May Personalize Cancer Treatment
“Osimertinib, for example, improved five-year survival among patients with resected EGFR-mutated lung cancer, while CAR-T therapy has produced durable remissions in some children and young adults with relapsed or refractory B-cell acute lymphoblastic leukemia.”